| Issue |
Med Sci (Paris)
Volume 35, Number 10, Octobre 2019
|
|
|---|---|---|
| Page(s) | 806 - 809 | |
| Section | Forum | |
| DOI | https://doi.org/10.1051/medsci/2019149 | |
| Published online | 18 October 2019 | |
Cent ans après, le retour de la phagothérapie ?
Chroniques génomiques
Phage therapy is back - maybe?
UMR 7268 ADÉS, Aix-Marseille, Université /EFS/CNRS; CoReBio PACA, case 901, Parc scientifique de Luminy, 13288 Marseille Cedex 09, France
Abstract
Bacteriophages were advocated as therapeutic agents more than a century ago, but the advent of antibiotics relegated them to a very minor role. Today, multi-drug resistant bacteria are a serious health problem, and phage therapy enjoys renewed interest. Recent publications show that it can be effective, but also highlight the serious logistic problems involved in using this approach.
© 2019 médecine/sciences – Inserm
Article publié sous les conditions définies par la licence Creative Commons Attribution License CC-BY (http://creativecommons.org/licenses/by/4.0), qui autorise sans restrictions l'utilisation, la diffusion, et la reproduction sur quelque support que ce soit, sous réserve de citation correcte de la publication originale.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.